Cargando…
Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
BACKGROUND: Alzheimer’s disease is a devastating neurodegenerative disorder. Its worldwide prevalence is over 24 million and is expected to double by 2040. Finding ways to prevent its cognitive decline is urgent. METHODS: A two-sample Mendelian randomization study was performed instrumenting glutami...
Autor principal: | Adams, Charleen D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020919/ https://www.ncbi.nlm.nih.gov/pubmed/32103921 http://dx.doi.org/10.2147/CIA.S239350 |
Ejemplares similares
-
Bi-directional Mendelian randomization of epithelial ovarian cancer and schizophrenia and uni-directional Mendelian randomization of schizophrenia on circulating 1- or 2-glycerophosphocholine metabolites
por: Adams, Charleen D., et al.
Publicado: (2019) -
Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study
por: Williams, Dylan M, et al.
Publicado: (2019) -
A Mendelian randomization study of telomere length and blood-cell traits
por: Adams, Charleen D., et al.
Publicado: (2020) -
Causal Association Between Obesity, Circulating Glutamine Levels, and Depression: A Mendelian Randomization Study
por: He, Ruixin, et al.
Publicado: (2022) -
A multivariable Mendelian randomization to appraise the pleiotropy between intelligence, education, and bipolar disorder in relation to schizophrenia
por: Adams, Charleen D.
Publicado: (2020)